| GTO ID | GTC3244 |
| Trial ID | NCT05623488 |
| Disease | Breast Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | huCAR-T-meso cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CAR T Cells in Mesothelin-Expressing Breast Cancer |
| Year | 2022 |
| Country | United States |
| Company sponsor | University of Pennsylvania |
| Other ID(s) | UPCC# 15122, IRB # 852205 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||